Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
32.15
+0.45 (1.42%)
At close: May 12, 2025, 4:00 PM
31.30
-0.85 (-2.64%)
Pre-market: May 13, 2025, 4:15 AM EDT
Supernus Pharmaceuticals Analyst Ratings
Total Analysts
2
Consensus Rating
Hold
Price Target
$36.00
Upside
+11.98%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $36 | Hold | Reiterates | $36 | +11.98% | Feb 26, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades $57 → $36 | Buy → Hold | Downgrades | $57 → $36 | +11.98% | Feb 19, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $41 → $36 | Buy → Hold | Downgrades | $41 → $36 | +11.98% | Sep 11, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $45 → $41 | Buy | Maintains | $45 → $41 | +27.53% | Feb 28, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $42 → $43 | Buy | Maintains | $42 → $43 | +33.75% | Nov 9, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $43 → $42 | Buy | Maintains | $43 → $42 | +30.64% | Oct 25, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $45 → $46 | Buy | Maintains | $45 → $46 | +43.08% | May 10, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $40 → $47 | Buy | Maintains | $40 → $47 | +46.19% | Jan 23, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $33 → $38 | Buy | Maintains | $33 → $38 | +18.20% | Aug 31, 2022 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $25 → $40 | Hold → Strong Buy | Upgrades | $25 → $40 | +24.42% | Apr 13, 2021 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $25 → $31 | Hold → Buy | Upgrades | $25 → $31 | -3.58% | Jun 16, 2020 |
| Jefferies | Jefferies | Hold Initiates $24 | Hold | Initiates | $24 | -25.35% | Jun 15, 2020 |
| Stifel | Stifel | Hold Maintains $25 → $24 | Hold | Maintains | $25 → $24 | -25.35% | Apr 16, 2020 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $55 → $23 | Strong Buy → Hold | Downgrades | $55 → $23 | -28.46% | Nov 7, 2019 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 6, 2019 |
| Mizuho | Mizuho | Strong Buy Maintains $61 → $63 | Strong Buy | Maintains | $61 → $63 | +95.96% | Dec 17, 2018 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.